Reorder Your Mounjaro Prescription With Instant Savings
£25 Off Every Mounjaro Reorder - Automatic Discount
As a returning customer, you automatically receive £25 off every Mounjaro order. Your discount applies at checkout without codes or complications. Single 2.5mg pens now £144.99 (RRP £169.99), 15mg pens £293.99 (RRP £318.99). Bundle packages start from £314.99 for Intro Duos, representing significant ongoing savings for your continued treatment.
Streamlined Reorder Process for Existing Patients
Your previous clinical assessment accelerates the reorder process. Simply complete a brief medical update, confirm your current dosage requirements, and proceed to payment. Our GPhC-registered pharmacists review your continuing suitability for tirzepatide treatment, ensuring safe ongoing prescription of this prescription-only medicine alongside your established diet and exercise routine.
Express Approval for Urgent Reorders
Need your Mounjaro prescription urgently? Upgrade to express 24-hour approval for fast-track processing. Standard 3 working day approval remains complimentary, but express service ensures your treatment continuity without interruption. Both options include full clinical review by our qualified prescribers and direct delivery to your chosen address.
Complete Range Available for Reorder
All Mounjaro strengths available for immediate reorder: 2.5mg (£144.99), 5mg (£174.99), 7.5mg (£224.99), 10mg (£244.99), 12.5mg (£274.99), and 15mg (£293.99). Progression bundles available if stepping up dosage: Progress Duo combining 5mg + 7.5mg pens (£384.99), Progress Trio with 5mg, 7.5mg, and 10mg (£649.99). Your prescriber will confirm appropriate strength progression.
Secure Your Continuing Mounjaro Supply
Maintain treatment consistency with regular reorders. This prescription-only injectable may help support your ongoing weight management goals when used alongside reduced-calorie diet and increased physical activity. Our MHRA-compliant service ensures continuing access to genuine tirzepatide, with each order subject to clinical review for safety and appropriateness.
